Skip to main content
Article
Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout Mice
PLOS ONE (2016)
  • Joseph F. Cubells, Emory University
  • Jason P. Schroeder, Emory University
  • Elizabeth S. Barrie, Ohio State University
  • Daniel F. Manvich, Rowan University School of Osteopathic Medicine
  • Wolfgang Sadee, Ohio State University
  • Tiina Berg, Emory University
  • Kristina Mercer, Emory University
  • Taylor A. Stowe, Emory University
  • L. Cameron Liles, Emory University
  • Katherine E. Squires, Emory University
  • Andrew Mezher
  • Patrick Curtin
  • Dannie L. Perdomo
  • Patricia Szot, United States Department of Veterans Affairs
  • David Weinshenker, Emory University
Abstract
Dopamine β-hydroxylase (DBH) converts dopamine (DA) to norepinephrine (NE) in noradrenergic/adrenergic cells. DBH deficiency prevents NE production and causes sympathetic failure, hypotension and ptosis in humans and mice; DBH knockout (Dbh -/-) mice reveal other NE deficiency phenotypes including embryonic lethality, delayed growth, and behavioral defects. Furthermore, a single nucleotide polymorphism (SNP) in the human DBH gene promoter (-970C>T; rs1611115) is associated with variation in serum DBH activity and with several neurological- and neuropsychiatric-related disorders, although its impact on DBH expression is controversial. Phenotypes associated with DBH deficiency are typically treated with L-3,4-dihydroxyphenylserine (DOPS), which can be converted to NE by aromatic acid decarboxylase (AADC) in the absence of DBH. In this study, we generated transgenic mice carrying a human bacterial artificial chromosome (BAC) encompassing the DBH coding locus as well as ~45 kb of upstream and ~107 kb of downstream sequence to address two issues. First, we characterized the neuroanatomical, neurochemical, physiological, and behavioral transgenic rescue of DBH deficiency by crossing the BAC onto a Dbh -/- background. Second, we compared human DBH mRNA abundance between transgenic lines carrying either a "C" or a "T" at position -970. The BAC transgene drove human DBH mRNA expression in a pattern indistinguishable from the endogenous gene, restored normal catecholamine levels to the peripheral organs and brain of Dbh -/- mice, and fully rescued embryonic lethality, delayed growth, ptosis, reduced exploratory activity, and seizure susceptibility. In some cases, transgenic rescue was superior to DOPS. However, allelic variation at the rs1611115 SNP had no impact on mRNA levels in any tissue. These results indicate that the human BAC contains all of the genetic information required for tissue-specific, functional expression of DBH and can rescue all measured Dbh deficiency phenotypes, but did not reveal an impact of the rs11115 variant on DBH expression in mice.
Keywords
  • Mice,
  • Neurons,
  • Biological Locomotion,
  • Gene Expression,
  • Phenotypes,
  • Catecholaminess,
  • Genome-wide Association Studies,
  • Oligonucleotides
Publication Date
May 5, 2016
DOI
10.1371/journal.pone.0154864
Publisher Statement
This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the
Creative Commons CC0 public domain dedication.
Citation Information
Joseph F. Cubells, Jason P. Schroeder, Elizabeth S. Barrie, Daniel F. Manvich, et al.. "Human Bacterial Artificial Chromosome (BAC) Transgenesis Fully Rescues Noradrenergic Function in Dopamine β-Hydroxylase Knockout Mice" PLOS ONE Vol. 11 Iss. 5 (2016)
Available at: http://works.bepress.com/daniel-manvich/3/